C
Cezary Szczylik
Researcher at Medical University of Warsaw
Publications - 291
Citations - 30393
Cezary Szczylik is an academic researcher from Medical University of Warsaw. The author has contributed to research in topics: Renal cell carcinoma & Cancer. The author has an hindex of 49, co-authored 274 publications receiving 27380 citations. Previous affiliations of Cezary Szczylik include Military Medical Academy & Cora.
Papers
More filters
Journal ArticleDOI
Which Parameters of Nutritional Status Should We Choose for Nutritional Assessment During Hematopoietic Stem Cell Transplantation
TL;DR: Changes in nutritional status parameters and acute phase protein levels as qualifications for TPN were analyzed and prealbumin level, measured 8 days after the end of the conditioning regimen was helpful to make a decision about starting TPN.
Journal Article
Targeted therapy of renal cell cancer.
TL;DR: Novel targeted agents - temsirolimus, sorafenib, sunitinib and bevacizumab - significantly prolonged progression-free survival of patients with metastatic RCC and, crucially, temsIROlimus also prolonged overall survival in patients with high-risk disease.
Journal ArticleDOI
Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies.
Aleksandra Klemba,Lubomir Bodnar,Halina Was,Klaudia Brodaczewska,Gabriel Wcisło,Cezary Szczylik,Claudine Kieda +6 more
TL;DR: This review focuses on the effects of hypoxia in the microenvironment and its consequences on tumor treatments, and opens the way to innovative combined treatments to the advantage of immunotherapy outcome in ovarian cancers.
Journal ArticleDOI
Biology of renal tumour cancer stem cells applied in medicine
Damian Matak,Lukasz Szymanski,Cezary Szczylik,Rafal Sledziewski,Fei Lian,Ewa Bartnik,Anna A. Sobocińska,Anna M. Czarnecka +7 more
TL;DR: The present article highlights the diverse role of stem cells in normal kidney and renal cancer, with special emphasis on surface markers, and state the current hypothesis about origin of tumour-initiating cells in RCC.